Oral Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors: Salivary Gland Dysfunction and Mucosal Diseases

SIMPLE SUMMARY: The antitumor effect of immune checkpoint inhibitors (ICIs) such as antibodies against CTLA-4, PD-1, and PD-L1 is higher than that of conventional chemotherapy and is durable, improving the survival of patients with advanced head and neck squamous cell carcinoma (HNSCC). However, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yura, Yoshiaki, Hamada, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834130/
https://www.ncbi.nlm.nih.gov/pubmed/35159059
http://dx.doi.org/10.3390/cancers14030792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834130/
https://www.ncbi.nlm.nih.gov/pubmed/35159059
http://dx.doi.org/10.3390/cancers14030792

Ejemplares similares